Friday, 18 May 2018

AstraZeneca hit by falling Crestor sales, shares fall

LONDON (Reuters) - AstraZeneca's first quarter profit was hit by generic competition to cholesterol fighter Crestor and higher costs, but the drugmaker expects a better second half and said it remained on track for a promised return to sales growth in 2018.


from Reuters: Top News http://uk.reuters.com/article/uk-astrazeneca-results/astrazeneca-hit-by-falling-crestor-sales-shares-fall-idUKKCN1IJ0GX?feedType=RSS&feedName=topNews

No comments:

Post a Comment